• Mashup Score: 1
    Best of ASCO - 10 month(s) ago

    Welcome to Best of ASCO – Lebanon! The Best of ASCO have been held annually in Lebanon since 2006. These meetings serve as a vital platform for oncologists to stay up-to-date of the latest advancements and practice-changing research in the dynamic field of cancer. Physicians from Lebanon and the surrounding region come together to listen, discuss, network, and socialize with their…

    Tweet Tweets with this article
    • Kickoff Best of #ASCO23 Lebanon. Welcome @AUB_Lebanon NKBCI LSMO AMAAC @ASCO @oncoalert https://t.co/w6yKoy41mc مؤتمر افضل ابحاث السرطان https://t.co/xNfqFGFd5A

  • Mashup Score: 1
    Best of ASCO - 10 month(s) ago

    Welcome to Best of ASCO – Lebanon! The Best of ASCO have been held annually in Lebanon since 2006. These meetings serve as a vital platform for oncologists to stay up-to-date of the latest advancements and practice-changing research in the dynamic field of cancer. Physicians from Lebanon and the surrounding region come together to listen, discuss, network, and socialize with their…

    Tweet Tweets with this article
    • https://t.co/H70jmncdIs Lebanon 7-8 July 2023 In-person & Hybrid from outside Lebanon. مؤتمر افضل ابحاث السرطان -2023 AUBMC للتذكير: اخر يوم للتسجيل 5 Registration deadline Reminder @ASCO @OncoAlert @AUB_Lebanon https://t.co/OdLbcKW8c5

  • Mashup Score: 7
    ASCO 2023 - Breast Cancer - 11 month(s) ago

    Outcomes with first-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs physician’s choice combination chemotherapy (combo CT) by age in pre/perimenopausal patients (pts) with aggressive HR+/HER2− advanced breast cancer (ABC): A subgroup analysis of the RIGHT Choice trial El Saghir N Presentation # 1063 – PosterJune 4, 2023 | …

    Tweet Tweets with this article
    • Proud to present RIGHT Choice trial subgroup analysis by age at #ASCO23 In Patients <40 with aggressive HR+ HER2- Advanced #breastcancer Cancer: #Ribociclib + ET (OFS + letrozole) PFS superior to combo chemo (HR 0.38) https://t.co/lAXQlfx5Yv @OncoAlert https://t.co/n3g38H1kzl

  • Mashup Score: 0

    Article: Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management

    Tweet Tweets with this article
    • Best weekly conferences: Grand Rounds at @AUBMC_Official! Thank U Guest Speaker: Doctor, Lawyer, Research, Germline Mutations & Humanity @GABOUALFA @MSKCancerCenter @FuadZiyadeh @drhibamoukadem @DrFadloKhuri Raymond Sawaya Faculty & Fellows @AUB_Lebanon https://t.co/Q1oKWvH4ov https://t.co/YX2lpvhdpb